S&P Picks and Pans: Amgen, St. Jude Medical, Verizon, American Express, DuPont

Fourth quarter EPS of $1.04, vs. $0.97, is in line with our estimate. Revenues were $80M below our forecast, offset by lower-than-expected expenses. AMGN sees flat 2009 revenue growth, with EPS gains from costs control. We maintain our view of denosumab


Leave a Reply